These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 33800954)

  • 41. Peripheral inflammation and blood-brain barrier disruption: effects and mechanisms.
    Huang X; Hussain B; Chang J
    CNS Neurosci Ther; 2021 Jan; 27(1):36-47. PubMed ID: 33381913
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neurological manifestations and comorbidity associated with COVID-19: an overview.
    Kumar M; Thakur AK
    Neurol Sci; 2020 Dec; 41(12):3409-3418. PubMed ID: 33052573
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Putative mechanism of neurological damage in COVID-19 infection.
    Bandala C; Cortes-Altamirano JL; Reyes-Long S; Lara-Padilla E; Ilizaliturri-Flores I; Alfaro-Rodríguez A
    Acta Neurobiol Exp (Wars); 2021; 81(1):69-79. PubMed ID: 33949163
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Microglial Regulation of Blood Brain Barrier, the Neuro-Immunological Interface].
    Ikegami A; Wake H
    Brain Nerve; 2021 Aug; 73(8):913-919. PubMed ID: 34376598
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The involvement of the central nervous system in patients with COVID-19.
    Saleki K; Banazadeh M; Saghazadeh A; Rezaei N
    Rev Neurosci; 2020 May; 31(4):453-456. PubMed ID: 32463395
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The COVID-19 infection in children and its association with the immune system, prenatal stress, and neurological complications.
    Khan S; Siddique R; Hao X; Lin Y; Liu Y; Wang X; Hua L; Nabi G
    Int J Biol Sci; 2022; 18(2):707-716. PubMed ID: 35002519
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Does SARS-Cov-2 invade the brain? Translational lessons from animal models.
    Natoli S; Oliveira V; Calabresi P; Maia LF; Pisani A
    Eur J Neurol; 2020 Sep; 27(9):1764-1773. PubMed ID: 32333487
    [TBL] [Abstract][Full Text] [Related]  

  • 48. COVID-19 and cognitive impairment: neuroinvasive and blood‒brain barrier dysfunction.
    Chen Y; Yang W; Chen F; Cui L
    J Neuroinflammation; 2022 Sep; 19(1):222. PubMed ID: 36071466
    [TBL] [Abstract][Full Text] [Related]  

  • 49. What HIV in the Brain Can Teach Us About SARS-CoV-2 Neurological Complications?
    Al-Harthi L; Campbell E; Schneider JA; Bennett DA
    AIDS Res Hum Retroviruses; 2021 Apr; 37(4):255-265. PubMed ID: 32683890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A review of the mechanisms of blood-brain barrier disruption during COVID-19 infection.
    Jamil Al-Obaidi MM; Desa MNM
    J Neurosci Res; 2023 Nov; 101(11):1687-1698. PubMed ID: 37462109
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19.
    Meinhardt J; Radke J; Dittmayer C; Franz J; Thomas C; Mothes R; Laue M; Schneider J; Brünink S; Greuel S; Lehmann M; Hassan O; Aschman T; Schumann E; Chua RL; Conrad C; Eils R; Stenzel W; Windgassen M; Rößler L; Goebel HH; Gelderblom HR; Martin H; Nitsche A; Schulz-Schaeffer WJ; Hakroush S; Winkler MS; Tampe B; Scheibe F; Körtvélyessy P; Reinhold D; Siegmund B; Kühl AA; Elezkurtaj S; Horst D; Oesterhelweg L; Tsokos M; Ingold-Heppner B; Stadelmann C; Drosten C; Corman VM; Radbruch H; Heppner FL
    Nat Neurosci; 2021 Feb; 24(2):168-175. PubMed ID: 33257876
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypoxia alters the expression of ACE2 and TMPRSS2 SARS-CoV-2 cell entry mediators in hCMEC/D3 brain endothelial cells.
    Imperio GE; Lye P; Mughis H; Hamada H; Bloise E; Lye SJ; Matthews SG
    Microvasc Res; 2021 Nov; 138():104232. PubMed ID: 34416267
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuro-COVID-19: an insidious virus in action.
    Bratosiewicz-Wąsik J
    Neurol Neurochir Pol; 2022; 56(1):48-60. PubMed ID: 34642927
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correlation between CNS Tuberculosis and the COVID-19 Pandemic: The Neurological and Therapeutic Insights.
    Mandal N; De N; Jana P; Sannigrahi A; Chattopadhyay K
    ACS Chem Neurosci; 2020 Sep; 11(18):2789-2792. PubMed ID: 32880441
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurological complications and infection mechanism of SARS-COV-2.
    Wan D; Du T; Hong W; Chen L; Que H; Lu S; Peng X
    Signal Transduct Target Ther; 2021 Nov; 6(1):406. PubMed ID: 34815399
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathological Features and Neuroinflammatory Mechanisms of SARS-CoV-2 in the Brain and Potential Therapeutic Approaches.
    Sodagar A; Javed R; Tahir H; Razak SIA; Shakir M; Naeem M; Yusof AHA; Sagadevan S; Hazafa A; Uddin J; Khan A; Al-Harrasi A
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883527
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?
    Burks SM; Rosas-Hernandez H; Alejandro Ramirez-Lee M; Cuevas E; Talpos JC
    Brain Behav Immun; 2021 Jul; 95():7-14. PubMed ID: 33412255
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration.
    Zhang L; Zhou L; Bao L; Liu J; Zhu H; Lv Q; Liu R; Chen W; Tong W; Wei Q; Xu Y; Deng W; Gao H; Xue J; Song Z; Yu P; Han Y; Zhang Y; Sun X; Yu X; Qin C
    Signal Transduct Target Ther; 2021 Sep; 6(1):337. PubMed ID: 34489403
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neurological manifestations of SARS-CoV-2 infections: towards quantum dots based management approaches.
    Almasi F; Mohammadipanah F
    J Drug Target; 2023 Jan; 31(1):51-64. PubMed ID: 35921123
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SARS-CoV-2 productively infects human brain microvascular endothelial cells.
    Yang RC; Huang K; Zhang HP; Li L; Zhang YF; Tan C; Chen HC; Jin ML; Wang XR
    J Neuroinflammation; 2022 Jun; 19(1):149. PubMed ID: 35705998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.